Concepedia

Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study

Jianjun Ou, Guanglei Xun, Renrong Wu, Lehua Li, Maosheng Fang, Honggeng Zhang, Shiping Xie, Jianguo Shi, Bo Du, Xue-Qin Yuan,

Psychopharmacology · 2010 · 27 citations · 31 references

DOI

Concepts

References

31

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

PubMed · 2000 · 514 citations

, , +16

Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients

W. J. Burke, I. Gergel, Anjana Bose · The Journal of Clinical Psychiatry · 2002 · 357 citations

, , +16

Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Ulla Lepola, Henrik Loft, Elin Heldbo Reines · International Clinical Psychopharmacology · 2003 · 225 citations

, , +15

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis

Sidney H. Kennedy, Henning Friis Andersen, Raymond W. Lam · Journal of Psychiatry and Neuroscience · 2006 · 218 citations

, , +16

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

Nicholas Moore, Bruno Fantino · International Clinical Psychopharmacology · 2005 · 190 citations

, , +14